MCL Featured Stories
Learn more about how Mayo Clinic Laboratories first-in-class insulin analogs assay uses liquid chromatography-high resolution mass spectrometry to provide clinicians with a highly specific way to identify and differentiate human insulin from multiple synthetic insulin analogs from a single blood sample. By overcoming the limitations of traditional immunoassays, the test delivers greater diagnostic clarity in complex hypoglycemia cases, helping clinicians reach accurate diagnoses faster and guide more effective patient care.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss seasonal vaccination planning and survey findings on laboratory industry growth. Later, Leslie Donato, Ph.D., a clinical chemist at Mayo Clinic, shares how an innovative testing panel is improving the diagnosis of bile acid malabsorption.
Specialized immunofluorescence testing helps uncover rare autoimmune blistering diseases, identify underlying cancers, and guide precise treatment, improving diagnostic accuracy and outcomes for patients with challenging skin disorders.
Join Mayo Clinic Laboratories and C2N Diagnostics for our webinar exploring how the evolution of blood biomarker testing for Alzheimer's disease has expanded access to earlier, less-invasive diagnosis. Focusing on the newly FDA-cleared PrecivityAD2 blood test, which is offered by Mayo Clinic Laboratories in collaboration with C2N Diagnostics, the discussion will highlight how results from blood biomarker testing can support timely diagnosis, informed clinical decision-making, and improved patient care.
Collaborating with Mayo Clinic Laboratories, UNC Health streamlined neuroimmunology test ordering — eliminating outmoded testing and elevating diagnostic accuracy.
Join Mayo Clinic Laboratories for our webinar exploring the expanding role of precision diagnostics in the evaluation of serious and potentially life-threatening infections. Focusing on metagenomic sequencing available from Mayo Clinic Laboratories, including the Karius Spectrum plasma test, which is offered by Mayo Clinic Laboratories in collaboration with Karius, participants will gain an overview of microbial cell-free DNA (mcfDNA) metagenomic sequencing, including clinical decision-making around test ordering, appropriate clinical indications, and how to interpret and apply results to support timely diagnosis and patient management.
Explore why traditional microscopy is challenging, how AI-assisted review works, what workflow changes are required, and how validation data can support implementation decisions.
Learn more about how Mayo Clinic’s Nerve Pathology Laboratory leverages decades of nerve pathology testing experience and unmatched clinical expertise to provide diagnostic clarity for rare and complex neuropathies.
Genome-wide methylation profiling is transforming the way clinicians approach brain tumor diagnosis. By analyzing epigenetic patterns across the genome, this advanced testing method provides a new level of precision, helping resolve ambiguous cases, reduce diagnostic variability, and support more confident clinical decision-making in complex CNS tumors.
Recording coming soon. Learn how GFAP testing is emerging as a biomarker to support diagnosis, monitoring, and prognosis in neurological diseases.
Join us at the 2026 Mayo Clinic Classical Hematology Conference: Nonmalignant Hematology and Bleeding and Thrombotic Disorders, where innovation, collaboration, and expertise come together to advance the field of hematology.
Tick-borne diseases are increasing across the United States as tick populations and their geographic range continue to expand. This presentation reviews current trends in tick-borne diseases, highlights major tick vectors and associated pathogens, discusses prevention strategies, and explores the laboratory's role in supporting accurate diagnosis and patient care.
Discover how Mayo Clinic’s nationally recognized Muscle Pathology Laboratory provides unparalleled diagnostic accuracy for rare muscle diseases through decades of experience, specialized testing, and integrated clinical-pathological evaluation.